"
Team:Tufts/future
From 2014.igem.org
(Difference between revisions)
| Line 27: | Line 27: | ||
<li data-target="#myCarousel" data-slide-to="2" class=""></li> | <li data-target="#myCarousel" data-slide-to="2" class=""></li> | ||
<li data-target="#myCarousel" data-slide-to="3" class=""></li> | <li data-target="#myCarousel" data-slide-to="3" class=""></li> | ||
| + | <li data-target="#myCarousel" data-slide-to="4" class=""></li> | ||
| + | |||
</ol> | </ol> | ||
<div class="carousel-inner"> | <div class="carousel-inner"> | ||
| Line 57: | Line 59: | ||
</div> | </div> | ||
</div> | </div> | ||
| + | <div class="item"> | ||
| + | <img src="https://static.igem.org/mediawiki/2014/9/92/C1.jpg " alt="Third slide" style="height: 350px; width: 100%; display: block;"> | ||
| + | <div class="container"> | ||
| + | <div class="carousel-caption"> | ||
| + | </div> | ||
| + | </div> | ||
| + | </div> | ||
| + | |||
</div> | </div> | ||
<a class="left carousel-control" href="#myCarousel" data-slide="prev"><span class="glyphicon glyphicon-chevron-left"></span></a> | <a class="left carousel-control" href="#myCarousel" data-slide="prev"><span class="glyphicon glyphicon-chevron-left"></span></a> | ||
Revision as of 01:35, 18 October 2014
This October, Tufts Synthetic Biology hosted a conference, The Future of Phage and Synthetic Biology, which brought together experts from academia, industry, and regulation to discuss and present on emerging research concerning the applications of phage - specifically bacteriophage therapy.
The conference incorporated two main events. The first a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage application and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
The conference incorporated two main events. The first a discussion between experts, held under Chatham House rules, to discuss and advance a pre-written framework for bacteriophage application and associated safety and regulatory considerations. This was followed by a public forum to present and discuss the results and implications with a more general audience before shifting to guided and informal discussion.
